Offer

Asthma and COPD are very common diseases, affecting hundreds of thousands of Swiss people. New biologics are now available for severe asthma. As nasal polyps and allergies often also play an important role in these patients, these patients are discussed in the presence of pulmonologists, allergists and ENT specialists. In advanced COPD, bronchoscopic and surgical methods of lung volume reduction are now available; the decision as to which method is most suitable for the individual patient is made together with pulmonologists, thoracic surgeons, radiologists and nuclear medicine specialists.

The lung tumor segment of the Lung Center is also an important partner of the University Tumor Center. The combination of different specialist disciplines forms the Center for Lung Tumors, within which all patients with lung cancer and other tumors in the area of the chest are treated. Experts from pneumology, thoracic surgery, oncology, radiation oncology, pathology, radiology and nuclear medicine take part in the weekly tumor conference. The combined expertise of various disciplines from the diagnostic and therapeutic spectrum enables rapid clarification and personalized therapy. This also applies to patients from the rest of north-western Switzerland, including the Jura: experts from oncology and pneumology at the Hôpital du Jura in Delémont take part in the meeting every week.

The University Sleep Center is certified together with the University Hospital Basel (USB), the University Children's Hospital Basel (UKBB) and the University Psychiatric Clinics (UPK). The necessary sleep examinations are carried out at all three locations. Complex cases are discussed at the interdisciplinary conference, which is attended by pulmonologists, neurologists and psychiatrists from the various clinics.

Lung infections have not only been common since COVID-19, but also affect immunocompromised patients in particular. In addition to rapid diagnosis, interdisciplinary management plays an important role in protracted infections. Accordingly, pulmonologists, infectious disease specialists, thoracic surgeons and radiologists take care of the optimal treatment proposals.

Interstitial lung diseases are associated with an increase in inflammatory cells and connective tissue in the lungs. There are many different causes, such as sarcoidosis or rheumatic diseases. In addition to the diagnostic classification, the therapy concepts are often based on analyzed cells and lung tissue, which is why pathologists regularly participate alongside pulmonologists and radiologists. If necessary, rheumatologists, cardiologists, neurologists and ophthalmologists are also consulted.

The USB and UKBB are European-certified specialist centers for cystic fibrosis, which is the most common genetic lung disease. In addition to new therapies, lung transplantation is also an option for advanced cystic fibrosis. The most common other indications for lung transplantation are advanced COPD and pulmonary fibrosis.

Pulmonary arterial hypertension (pulmonary hypertension) occurs when the blood experiences more resistance through the pulmonary vessels. In addition to investigating the cause, a right heart catheter is needed to determine the exact extent of the disease and initiate treatment. Close collaboration between pulmonologists is essential. As patients with rheumatic diseases often develop pulmonary hypertension, there is also close cooperation with rheumatologists.

Thoracic trauma is defined as an injury to the chest and/or lungs. In addition to the diagnosis, which requires a computer tomogram, surgical rib fixation options are now available.